The American Cancer Society has approved funding for nearly $800,000 to a Roswell Park Comprehensive Center researcher who is working on a kidney cancer vaccine.
John Ebos will receive a $792,000 multi-year grant as part of 110 national research and training grants worth $47.6 million that will fund investigators at 72 institutions across the nation.
Patients with metastatic kidney cancer often stop treatment when the tumor becomes resistant to drugs being used. In many cases, the tumor almost immediately begins to grow again. Ebos is studying a vaccine to inhibit such tumor growth to allow more time to allow for other treatment options.
“The American Cancer Society research grant has changed the momentum of my work, providing financial stability for my lab and allowing me to find answers to questions we have been asking for more than 10 years,” Ebos said.